Anti-Cancer Small Molecules
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
176
NCT02844777
Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis
Phase: Phase 2
Role: Lead Sponsor
Start: Jul 15, 2016
Completion: May 26, 2017
NCT03538951
Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis
Start: May 23, 2018
Completion: Dec 10, 2018
Loading map...